美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA211560"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
46708-392-30 46708-392 HUMAN PRESCRIPTION DRUG DAPAGLIFLOZIN DAPAGLIFLOZIN TABLET, FILM COATED ORAL 20260406 N/A ANDA ANDA211560 Alembic Pharmaceuticals Limited DAPAGLIFLOZIN 5 mg/1 30 TABLET, FILM COATED in 1 BOTTLE (46708-392-30)
46708-392-91 46708-392 HUMAN PRESCRIPTION DRUG DAPAGLIFLOZIN DAPAGLIFLOZIN TABLET, FILM COATED ORAL 20260406 N/A ANDA ANDA211560 Alembic Pharmaceuticals Limited DAPAGLIFLOZIN 5 mg/1 1000 TABLET, FILM COATED in 1 BOTTLE (46708-392-91)
46708-393-30 46708-393 HUMAN PRESCRIPTION DRUG DAPAGLIFLOZIN DAPAGLIFLOZIN TABLET, FILM COATED ORAL 20260406 N/A ANDA ANDA211560 Alembic Pharmaceuticals Limited DAPAGLIFLOZIN 10 mg/1 30 TABLET, FILM COATED in 1 BOTTLE (46708-393-30)
46708-393-91 46708-393 HUMAN PRESCRIPTION DRUG DAPAGLIFLOZIN DAPAGLIFLOZIN TABLET, FILM COATED ORAL 20260406 N/A ANDA ANDA211560 Alembic Pharmaceuticals Limited DAPAGLIFLOZIN 10 mg/1 1000 TABLET, FILM COATED in 1 BOTTLE (46708-393-91)
62332-392-30 62332-392 HUMAN PRESCRIPTION DRUG DAPAGLIFLOZIN DAPAGLIFLOZIN TABLET, FILM COATED ORAL 20260406 N/A ANDA ANDA211560 Alembic Pharmaceuticals Inc. DAPAGLIFLOZIN 5 mg/1 30 TABLET, FILM COATED in 1 BOTTLE (62332-392-30)
62332-392-91 62332-392 HUMAN PRESCRIPTION DRUG DAPAGLIFLOZIN DAPAGLIFLOZIN TABLET, FILM COATED ORAL 20260406 N/A ANDA ANDA211560 Alembic Pharmaceuticals Inc. DAPAGLIFLOZIN 5 mg/1 1000 TABLET, FILM COATED in 1 BOTTLE (62332-392-91)
62332-393-30 62332-393 HUMAN PRESCRIPTION DRUG DAPAGLIFLOZIN DAPAGLIFLOZIN TABLET, FILM COATED ORAL 20260406 N/A ANDA ANDA211560 Alembic Pharmaceuticals Inc. DAPAGLIFLOZIN 10 mg/1 30 TABLET, FILM COATED in 1 BOTTLE (62332-393-30)
62332-393-91 62332-393 HUMAN PRESCRIPTION DRUG DAPAGLIFLOZIN DAPAGLIFLOZIN TABLET, FILM COATED ORAL 20260406 N/A ANDA ANDA211560 Alembic Pharmaceuticals Inc. DAPAGLIFLOZIN 10 mg/1 1000 TABLET, FILM COATED in 1 BOTTLE (62332-393-91)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2026 Drugfuture->U.S. FDA National Drug Code DataBase